Cover Image

2',3',4'-Trihydroxychalcone changes estrogen receptor α regulation of genes and breast cancer cell proliferation by a reprogramming mechanism

Abstract Background Menopausal hormone therapy (MHT) is recommended for only five years to treat vasomotor symptoms and vulvovaginal atrophy because of safety concerns with long-term treatment. We investigated the ability of 2',3',4'-trihydroxychalcone (2',3',4'-THC) to...

Full description

Saved in:
Bibliographic Details
Main Authors: Candice B. Herber (Author), Chaoshen Yuan (Author), Anthony Chang (Author), Jen-Chywan Wang (Author), Isaac Cohen (Author), Dale C. Leitman (Author)
Format: Book
Published: BMC, 2022-04-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items